<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37566031</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1952</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12151952</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive degeneration of motor neurons (MNs). Astrocytes display a toxic phenotype in ALS, which results in MN damage. Glutamate (Glu)-mediated excitotoxicity and group I metabotropic glutamate receptors (mGluRs) play a pathological role in the disease progression. We previously demonstrated that in vivo genetic ablation or pharmacological modulation of mGluR5 reduced astrocyte activation and MN death, prolonged survival and ameliorated the clinical progression in the SOD1<sup>G93A</sup> mouse model of ALS. This study aimed to investigate in vitro the effects of mGluR5 downregulation on the reactive spinal cord astrocytes cultured from adult late symptomatic SOD1<sup>G93A</sup> mice. We observed that mGluR5 downregulation in SOD1<sup>G93A</sup> astrocytes diminished the cytosolic Ca<sup>2+</sup> overload under resting conditions and after mGluR5 simulation and reduced the expression of the reactive glial markers GFAP, S100&#x3b2; and vimentin. In vitro exposure to an anti-mGluR5 antisense oligonucleotide or to the negative allosteric modulator CTEP also ameliorated the altered reactive astrocyte phenotype. Downregulating mGluR5 in SOD1<sup>G93A</sup> mice reduced the synthesis and release of the pro-inflammatory cytokines IL-1&#x3b2;, IL-6 and TNF-&#x3b1; and ameliorated the cellular bioenergetic profile by improving the diminished oxygen consumption and ATP synthesis and by lowering the excessive lactate dehydrogenase activity. Most relevantly, mGluR5 downregulation hampered the neurotoxicity of SOD1<sup>G93A</sup> astrocytes co-cultured with spinal cord MNs. We conclude that selective reduction in mGluR5 expression in SOD1<sup>G93A</sup> astrocytes positively modulates the astrocyte reactive phenotype and neurotoxicity towards MNs, further supporting mGluR5 as a promising therapeutic target in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torazza</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provenzano</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallia</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerminara</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Paolo Daneo, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balbi</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonifacino</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3966-9874</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inter-University Center for the Promotion of the 3Rs Principles in Teaching &amp; Research (Centro 3R), 56122 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tessitore</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravera</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0803-1042</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine (DIMES), University of Genoa, Via Alberti L.B. 2, 16132 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usai</LastName><ForeName>Cesare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Biophysics, National Research Council (CNR), Via De Marini 6, 16149 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musante</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puliti</LastName><ForeName>Aldamaria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Paolo Daneo, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0104-4067</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute, KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB-Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafar-Nejad</LastName><ForeName>Paymaan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigo</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3384-0666</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Giambattista</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3744-5786</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber><NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578936">Grm5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064529">Receptor, Metabotropic Glutamate 5</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064529" MajorTopicYN="Y">Receptor, Metabotropic Glutamate 5</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Grm5 genetic ablation</Keyword><Keyword MajorTopicYN="N">SOD1G93A mice</Keyword><Keyword MajorTopicYN="N">adult mouse spinal cord astrocytes</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">mGlu5 receptor</Keyword></KeywordList><CoiStatement>The authors declare no competing interests. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. P.J.-n. and F.R. are paid employees of Ionis Pharmaceuticals.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37566031</ArticleId><ArticleId IdType="pmc">PMC10416852</ArticleId><ArticleId IdType="doi">10.3390/cells12151952</ArticleId><ArticleId IdType="pii">cells12151952</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Jr. Amyotrophic Lateral Sclerosis: Recent Insights from Genetics and Transgenic Mice. Cell. 1995;80:687&#x2013;692. doi: 10.1016/0092-8674(95)90346-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90346-1</ArticleId><ArticleId IdType="pubmed">7889564</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A. Amyotrophic Lateral Sclerosis-Evolutionary and Other Perspectives. Muscle Nerve. 2009;40:297&#x2013;304. doi: 10.1002/mus.21404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21404</ArticleId><ArticleId IdType="pubmed">19609920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The Phenotypic Variability of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W., Ahmed R., Mahoney C.J., Nguyen C., Tu S., Caga J., Loh P., Lin C.S.-Y., Kiernan M.C. The Impact of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis. Expert Rev. Neurother. 2020;20:281&#x2013;293. doi: 10.1080/14737175.2020.1727740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1727740</ArticleId><ArticleId IdType="pubmed">32031423</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Rouleau G.A., Ravits J., Cashman N.R. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS) Cold Spring Harb. Perspect. Med. 2017;7:a024117. doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecoraro V., Mandrioli J., Carone C., Chi&#xf2; A., Traynor B.J., Trenti T. The NGS Technology for the Identification of Genes Associated with the ALS. A Systematic Review. Eur. J. Clin. Investig. 2020;50:e13228. doi: 10.1111/eci.13228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13228</ArticleId><ArticleId IdType="pmc">PMC9008463</ArticleId><ArticleId IdType="pubmed">32293029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Battistini S., Calvo A., Caponnetto C., Conforti F.L., Corbo M., Giannini F., Mandrioli J., Mora G., Sabatelli M., et al. Genetic Counselling in ALS: Facts, Uncertainties and Clinical Suggestions. J. Neurol. Neurosurg. Psychiatry. 2014;85:478&#x2013;485. doi: 10.1136/jnnp-2013-305546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305546</ArticleId><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Zerbo R.A., Balbi M., Torazza C., Frumento G., Fedele E., Bonanno G., Milanese M. Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives. Int. J. Mol. Sci. 2021;22:12236. doi: 10.3390/ijms222212236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212236</ArticleId><ArticleId IdType="pmc">PMC8619465</ArticleId><ArticleId IdType="pubmed">34830115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Dong Le W., Xie Y.-Y., Wang X.-P. Current Therapy of Drugs in Amyotrophic Lateral Sclerosis. Curr. Neuropharmacol. 2016;14:314&#x2013;321. doi: 10.2174/1570159X14666160120152423.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X14666160120152423</ArticleId><ArticleId IdType="pmc">PMC4876587</ArticleId><ArticleId IdType="pubmed">26786249</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K., et al. Safety and Efficacy of Edaravone in Well Defined Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Cudkowicz M.E., Genge A., Miller T.M., Cudkowicz M.E., Genge A., Shaw P.J., Sobue G., Bucelli R.C., Chi&#xf2; A., et al. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2022;387:1099&#x2013;1110. doi: 10.1056/NEJMoa2204705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204705</ArticleId><ArticleId IdType="pubmed">36129998</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Wuu J., Andersen P.M., Bucelli R.C., Andrews J.A., Otto M., Farahany N.A., Harrington E.A., Chen W., Mitchell A.A., et al. Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: The ATLAS Study. Neurotherapeutics. 2022;19:1686. doi: 10.1007/s13311-022-01286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01286-9</ArticleId><ArticleId IdType="pmc">PMC9587202</ArticleId><ArticleId IdType="pubmed">35585374</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B.M., Morrison J.H. Amyotrophic Lateral Sclerosis Associated with Mutations in Superoxide Dismutase: A Putative Mechanism of Degeneration. Brain Res. Rev. 1999;29:121&#x2013;135. doi: 10.1016/S0165-0173(98)00049-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0173(98)00049-6</ArticleId><ArticleId IdType="pubmed">9974153</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Zappettini S., Onofri F., Musazzi L., Tardito D., Bonifacino T., Messa M., Racagni G., Usai C., Benfenati F., et al. Abnormal Exocytotic Release of Glutamate in a Mouse Model of Amyotrophic Lateral Sclerosis. J. Neurochem. 2011;116:1028&#x2013;1042. doi: 10.1111/j.1471-4159.2010.07155.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07155.x</ArticleId><ArticleId IdType="pubmed">21175617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular Pathways of Motor Neuron Injury in Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor Neuron Vulnerability and Resistance in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall L., Anakor E., Connolly O., Vijayakumar U.G., Duddy W.J., Duguez S. Molecular and Cellular Mechanisms Affected in ALS. J. Pers. Med. 2020;10:101. doi: 10.3390/jpm10030101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10030101</ArticleId><ArticleId IdType="pmc">PMC7564998</ArticleId><ArticleId IdType="pubmed">32854276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W., Parpura V. Spatio-Temporal Characteristics of Metabotropic Glutamate Receptor 5 Traffic at or near the Plasma Membrane in Astrocytes. Glia. 2016;64:1050&#x2013;1065. doi: 10.1002/glia.22982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22982</ArticleId><ArticleId IdType="pubmed">27014856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z., Ba L., Zhang M. Dysfunction of the Oligodendrocytes in Amyotrophic Lateral Sclerosis. J. Biomed. Res. 2022;36:336&#x2013;342. doi: 10.7555/JBR.36.20220009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7555/JBR.36.20220009</ArticleId><ArticleId IdType="pmc">PMC9548435</ArticleId><ArticleId IdType="pubmed">36106501</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C.V., Cleveland D.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non&#x2013;Cell Autonomous Toxicity in Neurodegenerative Disorders: ALS and Beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweingruber C., Hedlund E. The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis. Biology. 2022;11:1191. doi: 10.3390/biology11081191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11081191</ArticleId><ArticleId IdType="pmc">PMC9405388</ArticleId><ArticleId IdType="pubmed">36009818</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Harten A.C.M.M., Phatnani H., Przedborski S. Non-Cell-Autonomous Pathogenic Mechanisms in Amyotrophic Lateral Sclerosis. Trends Neurosci. 2021;44:658&#x2013;668. doi: 10.1016/j.tins.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8972039</ArticleId><ArticleId IdType="pubmed">34006386</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-Cell Autonomous Effect of Glia on Motor Neurons in an Embryonic Stem Cell-Based ALS Model. Nat. Neurosci. 2007;10:608&#x2013;614. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Appel S.H. Immune Dysregulation in Amyotrophic Lateral Sclerosis: Mechanisms and Emerging Therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as Determinants of Disease Progression in Inherited Amyotrophic Lateral Sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective Loss of Glial Glutamate Transporter GLT-1 in Amyotrophic Lateral Sclerosis. Ann. Neurol. 1995;38:73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Musazzi L., Milanese M., Seguini M., Marte A., Gallia E., Cattaneo L., Onofri F., Popoli M., Bonanno G. Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. Neurobiol. Dis. 2016;95:122&#x2013;133. doi: 10.1016/j.nbd.2016.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.07.011</ArticleId><ArticleId IdType="pubmed">27425885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Rebosio C., Provenzano F., Torazza C., Balbi M., Milanese M., Raiteri L., Usai C., Fedele E., Bonanno G. Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression. Int. J. Mol. Sci. 2019;20:4552. doi: 10.3390/ijms20184552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184552</ArticleId><ArticleId IdType="pmc">PMC6774337</ArticleId><ArticleId IdType="pubmed">31540330</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J., Ince P.G. Glutamate, Excitotoxicity and Amyotrophic Lateral Sclerosis. Springer; Berlin/Heidelberg, Germany: 1997.</Citation><ArticleIdList><ArticleId IdType="pubmed">9178165</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., Meininger V. Glutamate Levels in Cerebrospinal Fluid in Amyotrophic Lateral Sclerosis: A Reappraisal Using a New HPLC Method with Coulometric Detection in a Large Cohort of Patients. J. Neurol. Sci. 2002;193:73&#x2013;78. doi: 10.1016/S0022-510X(01)00661-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00661-X</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A., Andersen P.M., Moritz T., Marklund S.L., Antti H. ALS Patients with Mutations in the SOD1 Gene Have an Unique Metabolomic Profile in the Cerebrospinal Fluid Compared with ALS Patients without Mutations. Mol. Genet. Metab. 2012;105:472&#x2013;478. doi: 10.1016/j.ymgme.2011.11.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2011.11.201</ArticleId><ArticleId IdType="pubmed">22264771</ArticleId></ArticleIdList></Reference><Reference><Citation>Danbolt N.C. Glutamate Uptake. Prog. Neurobiol. 2001;65:1&#x2013;105. doi: 10.1016/S0301-0082(00)00067-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(00)00067-8</ArticleId><ArticleId IdType="pubmed">11369436</ArticleId></ArticleIdList></Reference><Reference><Citation>Maragakis N.J., Dykes-Hoberg M., Rothstein J.D. Altered Expression of the Glutamate Transporter EAAT2b in Neurological Disease. Ann. Neurol. 2004;55:469&#x2013;477. doi: 10.1002/ana.20003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20003</ArticleId><ArticleId IdType="pubmed">15048885</ArticleId></ArticleIdList></Reference><Reference><Citation>Raiteri L., Paolucci E., Prisco S., Raiteri M., Bonanno G. Activation of a Glycine Transporter on Spinal Cord Neurons Causes Enhanced Glutamate Release in a Mouse Model of Amyotrophic Lateral Sclerosis. Br. J. Pharmacol. 2003;138:1021&#x2013;1025. doi: 10.1038/sj.bjp.0705142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0705142</ArticleId><ArticleId IdType="pmc">PMC1573752</ArticleId><ArticleId IdType="pubmed">12684256</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Bonifacino T., Fedele E., Rebosio C., Cattaneo L., Benfenati F., Usai C., Bonanno G. Exocytosis Regulates Trafficking of GABA and Glycine Heterotransporters in Spinal Cord Glutamatergic Synapses: A Mechanism for the Excessive Heterotransporter-Induced Release of Glutamate in Experimental Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2015;74:314&#x2013;324. doi: 10.1016/j.nbd.2014.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.004</ArticleId><ArticleId IdType="pubmed">25497732</ArticleId></ArticleIdList></Reference><Reference><Citation>Armada-Moreira A., Gomes J.I., Pina C.C., Savchak O.K., Gon&#xe7;alves-Ribeiro J., Rei N., Pinto S., Morais T.P., Martins R.S., Ribeiro F.F., et al. Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases. Front. Cell Neurosci. 2020;14:90. doi: 10.3389/fncel.2020.00090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00090</ArticleId><ArticleId IdType="pmc">PMC7194075</ArticleId><ArticleId IdType="pubmed">32390802</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama M., Kato Y., Kakita A., Noguchi N., Urano Y., Masui K., Niida-Kawaguchi M., Yamamoto T., Watabe K., Kitagawa K., et al. Astrocytes Release Glutamate via Cystine/Glutamate Antiporter Upregulated in Response to Increased Oxidative Stress Related to Sporadic Amyotrophic Lateral Sclerosis. Neuropathology. 2020;40:587&#x2013;598. doi: 10.1111/neup.12716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12716</ArticleId><ArticleId IdType="pubmed">33305472</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Van Damme P., Bogaert E., Robberecht W. The Role of Excitotoxicity in the Pathogenesis of Amyotrophic Lateral Sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M., Carunchio I., Curcio L., Mercuri N.B., Zona C. Increased Persistent Sodium Current Determines Cortical Hyperexcitability in a Genetic Model of Amyotrophic Lateral Sclerosis. Exp. Neurol. 2009;215:368&#x2013;379. doi: 10.1016/j.expneurol.2008.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2008.11.002</ArticleId><ArticleId IdType="pubmed">19071115</ArticleId></ArticleIdList></Reference><Reference><Citation>King A.E., Woodhouse A., Kirkcaldie M.T.K., Vickers J.C. Excitotoxicity in ALS: Overstimulation, or Overreaction? Pt 1Exp. Neurol. 2016;275:162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno V., Caraci F., Copani A., Matrisciano F., Nicoletti F., Battaglia G. The Impact of Metabotropic Glutamate Receptors into Active Neurodegenerative Processes: A &#x201c;Dark Side&#x201d; in the Development of New Symptomatic Treatments for Neurologic and Psychiatric Disorders. Neuropharmacology. 2017;115:180&#x2013;192. doi: 10.1016/j.neuropharm.2016.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.04.044</ArticleId><ArticleId IdType="pubmed">27140693</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Van Vliet E.A., Mayboroda O.A., Troost D., Lopes Da Silva F.H., Gorter J.A. Upregulation of Metabotropic Glutamate Receptor Subtype MGluR3 and MGluR5 in Reactive Astrocytes in a Rat Model of Mesial Temporal Lobe Epilepsy. Eur. J. Neurosci. 2000;12:2333&#x2013;2344. doi: 10.1046/j.1460-9568.2000.00131.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.2000.00131.x</ArticleId><ArticleId IdType="pubmed">10947812</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Gorter J.A., Ijlst-Keizers H., Rozemuller A.J., Yankaya B., Leenstra S., Troost D. Expression and Functional Role of MGluR3 and MGluR5 in Human Astrocytes and Glioma Cells: Opposite Regulation of Glutamate Transporter Proteins. Eur. J. Neurosci. 2003;17:2106&#x2013;2118. doi: 10.1046/j.1460-9568.2003.02657.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.2003.02657.x</ArticleId><ArticleId IdType="pubmed">12786977</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Catania M.V., Geurts J., Yankaya B., Troost D. Immunohistochemical Localization of Group I and II Metabotropic Glutamate Receptors in Control and Amyotrophic Lateral Sclerosis Human Spinal Cord: Upregulation in Reactive Astrocytes. Neuroscience. 2001;105:509&#x2013;520. doi: 10.1016/S0306-4522(01)00181-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(01)00181-6</ArticleId><ArticleId IdType="pubmed">11672616</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownell A.L., Kuruppu D., Kil K.E., Jokivarsi K., Poutiainen P., Zhu A., Maxwell M. PET Imaging Studies Show Enhanced Expression of MGluR5 and Inflammatory Response during Progressive Degeneration in ALS Mouse Model Expressing SOD1-G93A Gene. J. Neuroinflamm. 2015;12:217. doi: 10.1186/s12974-015-0439-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0439-9</ArticleId><ArticleId IdType="pmc">PMC4657381</ArticleId><ArticleId IdType="pubmed">26597638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E., Volterra A. Focal Degeneration of Astrocytes in Amyotrophic Lateral Sclerosis. Cell Death Differ. 2008;15:1691&#x2013;1700. doi: 10.1038/cdd.2008.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.99</ArticleId><ArticleId IdType="pubmed">18617894</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F., Brambilla L., Valori C.F., Bergamaschi C., Roncoroni C., Aronica E., Volterra A., Bezzi P., Rossi D. The BH4 Domain of Bcl-X(L) Rescues Astrocyte Degeneration in Amyotrophic Lateral Sclerosis by Modulating Intracellular Calcium Signals. Hum. Mol. Genet. 2012;21:826&#x2013;840. doi: 10.1093/hmg/ddr513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr513</ArticleId><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Cattaneo L., Gallia E., Puliti A., Melone M., Provenzano F., Bossi S., Musante I., Usai C., Conti F., et al. In-Vivo Effects of Knocking-down Metabotropic Glutamate Receptor 5 in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Neuropharmacology. 2017;123:433&#x2013;445. doi: 10.1016/j.neuropharm.2017.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.06.020</ArticleId><ArticleId IdType="pubmed">28645622</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Bonifacino T., Torazza C., Provenzano F., Kumar M., Ravera S., Zerbo A.R., Frumento G., Balbi M., Nguyen T.P.N., et al. Blocking Glutamate MGlu(5) Receptors with the Negative Allosteric Modulator CTEP Improves Disease Course in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Br. J. Pharmacol. 2021;178:3747&#x2013;3764. doi: 10.1111/bph.15515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15515</ArticleId><ArticleId IdType="pmc">PMC8457068</ArticleId><ArticleId IdType="pubmed">33931856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.-X., et al. Motor Neuron Degeneration in Mice That Express a Human Cu,Zn Superoxide Dismutase Mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y.-M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., Roder J.C. Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP. J. Neurosci. 1997;17:5196&#x2013;5205. doi: 10.1523/JNEUROSCI.17-13-05196.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.17-13-05196.1997</ArticleId><ArticleId IdType="pmc">PMC6573299</ArticleId><ArticleId IdType="pubmed">9185557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Provenzano F., Gallia E., Ravera S., Torazza C., Bossi S., Ferrando S., Puliti A., Van Den Bosch L., Bonanno G., et al. In-Vivo Genetic Ablation of Metabotropic Glutamate Receptor Type 5 Slows down Disease Progression in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2019;129:79&#x2013;92. doi: 10.1016/j.nbd.2019.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.05.007</ArticleId><ArticleId IdType="pubmed">31102766</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A., Milanese M., Principato M.C., Morando S., Bonifacino T., Vergani L., Giunti D., Voci A., Carminati E., Giribaldi F., et al. Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis. Mol. Med. 2012;18:794&#x2013;804. doi: 10.2119/molmed.2011.00498.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00498</ArticleId><ArticleId IdType="pmc">PMC3409288</ArticleId><ArticleId IdType="pubmed">22481270</ArticleId></ArticleIdList></Reference><Reference><Citation>Provenzano F., Nyberg S., Giunti D., Torazza C., Parodi B., Bonifacino T., Usai C., Kerlero de Rosbo N., Milanese M., Uccelli A., et al. Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS. Cells. 2022;11:3923. doi: 10.3390/cells11233923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11233923</ArticleId><ArticleId IdType="pmc">PMC9741322</ArticleId><ArticleId IdType="pubmed">36497181</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini C., Cossu V., Kumar M., Milanese M., Cortese K., Bruno S., Bellese G., Carta S., Zerbo R.A., Torazza C., et al. The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Antioxidants. 2021;10:1392. doi: 10.3390/antiox10091392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10091392</ArticleId><ArticleId IdType="pmc">PMC8472526</ArticleId><ArticleId IdType="pubmed">34573024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford M.M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976;72:248&#x2013;254. doi: 10.1016/0003-2697(76)90527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(76)90527-3</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Manders E.M.M., Verbeek F.J., Aten J.A. Measurement of Co-Localization of Objects in Dual-Colour Confocal Images. J. Microsc. 1993;169:375&#x2013;382. doi: 10.1111/j.1365-2818.1993.tb03313.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.1993.tb03313.x</ArticleId><ArticleId IdType="pubmed">33930978</ArticleId></ArticleIdList></Reference><Reference><Citation>Costes S.V., Daelemans D., Cho E.H., Dobbin Z., Pavlakis G., Lockett S. Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells. Biophys. J. 2004;86:3993&#x2013;4003. doi: 10.1529/biophysj.103.038422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.103.038422</ArticleId><ArticleId IdType="pmc">PMC1304300</ArticleId><ArticleId IdType="pubmed">15189895</ArticleId></ArticleIdList></Reference><Reference><Citation>McCloy R.A., Rogers S., Caldon C.E., Lorca T., Castro A., Burgess A. Partial Inhibition of Cdk1 in G 2 Phase Overrides the SAC and Decouples Mitotic Events. Cell Cycle. 2014;13:1400&#x2013;1412. doi: 10.4161/cc.28401.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.28401</ArticleId><ArticleId IdType="pmc">PMC4050138</ArticleId><ArticleId IdType="pubmed">24626186</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakic B., Buszko M., Cappellano G., Wick G. Elevated Sodium Leads to the Increased Expression of HSP60 and Induces Apoptosis in HUVECs. PLoS ONE. 2017;12:e0179383. doi: 10.1371/journal.pone.0179383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179383</ArticleId><ArticleId IdType="pmc">PMC5467851</ArticleId><ArticleId IdType="pubmed">28604836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi P.I.A., Musante I., Summa M., Pittaluga A., Emionite L., Ikehata M., Rastaldi M.P., Ravazzolo R., Puliti A. Compensatory Molecular and Functional Mechanisms in Nervous System of the Grm1crv4 Mouse Lacking the MGlu1 Receptor: A Model for Motor Coordination Deficits. Cereb. Cortex. 2013;23:2179&#x2013;2189. doi: 10.1093/cercor/bhs200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhs200</ArticleId><ArticleId IdType="pubmed">22791805</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2&#x2212;&#x394;&#x394;CT Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Grynkiewicz G., Poenie M., Tsien R.Y. A New Generation of Ca2+ Indicators with Greatly Improved Fluorescence Properties. J. Biol. Chem. 1985;260:3440&#x2013;3450. doi: 10.1016/S0021-9258(19)83641-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)83641-4</ArticleId><ArticleId IdType="pubmed">3838314</ArticleId></ArticleIdList></Reference><Reference><Citation>Swayze E.E., Siwkowski A.M., Wancewicz E.V., Migawa M.T., Wyrzykiewicz T.K., Hung G., Monia B.P., Bennett C.F. Antisense Oligonucleotides Containing Locked Nucleic Acid Improve Potency but Cause Significant Hepatotoxicity in Animals. Nucleic Acids Res. 2007;35:687&#x2013;700. doi: 10.1093/nar/gkl1071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl1071</ArticleId><ArticleId IdType="pmc">PMC1802611</ArticleId><ArticleId IdType="pubmed">17182632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindemann L., Jaeschke G., Michalon A., Vieira E., Honer M., Spooren W., Porter R., Hartung T., Kolczewski S., B&#xfc;ttelmann B., et al. CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor. J. Pharmacol. Exp. Ther. 2011;339:474&#x2013;486. doi: 10.1124/jpet.111.185660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.111.185660</ArticleId><ArticleId IdType="pubmed">21849627</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfei S., Baig I. An Optimized and Very Detailed, Grams Scale Synthesis of CTEP, through a Complete Characterization of All the Isolated and Purified Intermediates. Org. Commun. 2017;10:114&#x2013;121. doi: 10.25135/acg.oc.15.16.11.444.</Citation><ArticleIdList><ArticleId IdType="doi">10.25135/acg.oc.15.16.11.444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Cossu V., Tappino B., Nicchia E., Dufour C., Cavani S., Sciutto A., Bolognesi C., Columbaro M., Degan P., et al. Concentration-dependent Metabolic Effects of Metformin in Healthy and Fanconi Anemia Lymphoblast Cells. J. Cell. Physiol. 2018;233:1736&#x2013;1751. doi: 10.1002/jcp.26085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26085</ArticleId><ArticleId IdType="pubmed">28681917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkle P.C. P/O Ratios of Mitochondrial Oxidative Phosphorylation. Biochim. Biophys. Acta Bioenerg. 2005;1706:1&#x2013;11. doi: 10.1016/j.bbabio.2004.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2004.09.004</ArticleId><ArticleId IdType="pubmed">15620362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi G., Martella R., Ravera S., Marini C., Capitanio S., Orengo A., Emionite L., Lavarello C., Amaro A., Petretto A., et al. Fasting Induces Anti-Warburg Effect That Increases Respiration but Reduces ATP-Synthesis to Promote Apoptosis in Colon. Cancer Models. 2015;6:11806&#x2013;11819. doi: 10.18632/oncotarget.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.3688</ArticleId><ArticleId IdType="pmc">PMC4494906</ArticleId><ArticleId IdType="pubmed">25909219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Bonifacino T., Bartolucci M., Milanese M., Gallia E., Provenzano F., Cortese K., Panfoli I., Bonanno G. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1&#xa0;G93A Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2018;55:9220&#x2013;9233. doi: 10.1007/s12035-018-1059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelli E., Cuccarolo P., Stroppiana G., Miano M., Bottega R., Cossu V., Degan P., Ravera S. Defects in Mitochondrial Energetic Function Compels Fanconi Anaemia Cells to Glycolytic Metabolism. Biochim. Biophys. Acta&#x2014;Mol. Basis Dis. 2017;1863:1214&#x2013;1221. doi: 10.1016/j.bbadis.2017.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2017.03.008</ArticleId><ArticleId IdType="pubmed">28315453</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Tardito D., Musazzi L., Treccani G., Mallei A., Bonifacino T., Gabriel C., Mocaer E., Racagni G., Popoli M., et al. Chronic Treatment with Agomelatine or Venlafaxine Reduces Depolarization-Evoked Glutamate Release from Hippocampal Synaptosomes. BMC Neurosci. 2013;14:75. doi: 10.1186/1471-2202-14-75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-14-75</ArticleId><ArticleId IdType="pmc">PMC3734058</ArticleId><ArticleId IdType="pubmed">23895555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonalume V., Caffino L., Castelnovo L.F., Faroni A., Liu S., Hu J., Milanese M., Bonanno G., Sohns K., Hoffmann T., et al. Axonal GABAA Stabilizes Excitability in Unmyelinated Sensory Axons Secondary to NKCC1 Activity. J. Physiol. 2021;599:4065&#x2013;4084. doi: 10.1113/JP279664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP279664</ArticleId><ArticleId IdType="pubmed">34174096</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberghe W., Van Den Bosch L., Robberecht W. Glial Cells Potentiate Kainate-Induced Neuronal Death in a Motoneuron-Enriched Spinal Coculture System. Brain Res. 1998;807:1&#x2013;10. doi: 10.1016/S0006-8993(98)00569-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(98)00569-1</ArticleId><ArticleId IdType="pubmed">9756982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese S., Herrmann T., Drepper C., Jablonka S., Funk N., Klausmeyer A., Rogers M.-L.L., Rush R., Sendtner M. Isolation and Enrichment of Embryonic Mouse Motoneurons from the Lumbar Spinal Cord of Individual Mouse Embryos. Nat. Protoc. 2010;5:31&#x2013;38. doi: 10.1038/nprot.2009.193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.193</ArticleId><ArticleId IdType="pubmed">20057379</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antoni S., Berretta A., Bonaccorso C.M., Bruno V., Aronica E., Nicoletti F., Catania M.V. Metabotropic Glutamate Receptors in Glial Cells. Neurochem. Res. 2008;33:2436&#x2013;2443. doi: 10.1007/s11064-008-9694-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-008-9694-9</ArticleId><ArticleId IdType="pubmed">18438710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., Ng S.K., Diaz N., Burstein S., Morel L., Osgood A., Sider B., Higashimori H., Haydon P.G., Manfredi G., et al. Abnormal Intracellular Calcium Signaling and SNARE Dependent Exocytosis Contributes to SOD1G93A Astrocyte- Mediated Toxicity in Amyotrophic Lateral Sclerosis. J. Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Rodriguez-Muela N., Klim J.R., de Boer A.S., Agrawal S., Sandoe J., Lopes C.S., Ogliari K.S., Williams L.A., Shear M., et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-&#x3b2;1. Stem Cell Reports. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes Expressing ALS-Linked Mutant FUS Induce Motor Neuron Death through Release of Tumor Necrosis Factor-Alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D., Cordera S., Cavalla P., Migheli A. Reactive Astrogliosis of the Spinal Cord in Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 1996;139:27&#x2013;33. doi: 10.1016/0022-510X(96)00073-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00073-1</ArticleId><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman R.D., Khuon S., Chou Y.H., Opal P., Steinert P.M. The Function of Intermediate Filaments in Cell Shape and Cytoskeletal Integrity. J. Cell Biol. 1996;134:971&#x2013;983. doi: 10.1083/jcb.134.4.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.4.971</ArticleId><ArticleId IdType="pmc">PMC2120965</ArticleId><ArticleId IdType="pubmed">8769421</ArticleId></ArticleIdList></Reference><Reference><Citation>Benninger F., Glat M.J., Offen D., Steiner I. Glial Fibrillary Acidic Protein as a Marker of Astrocytic Activation in the Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis. J. Clin. Neurosci. 2016;26:75&#x2013;78. doi: 10.1016/j.jocn.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2015.10.008</ArticleId><ArticleId IdType="pubmed">26602604</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano A., Donno C., Giannetti S., Peri&#x107; M., Andjus P., D&#x2019;Ambrosi N., Michetti F. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes. Mediat. Inflamm. 2017;2017:1626204. doi: 10.1155/2017/1626204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1626204</ArticleId><ArticleId IdType="pmc">PMC5496121</ArticleId><ArticleId IdType="pubmed">28713206</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Elrahman K.S., Hamilton A., Hutchinson S.R., Liu F., Russell R.C., Ferguson S.S.G. MGluR5 Antagonism Increases Autophagy and Prevents Disease Progression in the ZQ175 Mouse Model of Huntington&#x2019;s Disease. Sci. Signal. 2017;10:eaan6387. doi: 10.1126/scisignal.aan6387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aan6387</ArticleId><ArticleId IdType="pubmed">29259100</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer K., Abd-Elrahman K.S., Derksen A., Rowe E.M., Thompson A.M., Rudyk C.A., Prowse N.A., Dwyer Z., Bureau S.C., Fortin T., et al. MGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson&#x2019;s Disease. Mol. Neurobiol. 2020;57:1418&#x2013;1431. doi: 10.1007/s12035-019-01818-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01818-z</ArticleId><ArticleId IdType="pubmed">31754998</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant Superoxide Dismutase 1-Induced IL-1&#x3b2; Accelerates ALS Pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellezza I., Grottelli S., Costanzi E., Scarpelli P., Pigna E., Morozzi G., Mezzasoma L., Peirce M.J., Moresi V., Adamo S., et al. Peroxynitrite Activates the NLRP3 Inflammasome Cascade in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2018;55:2350&#x2013;2361. doi: 10.1007/s12035-017-0502-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0502-x</ArticleId><ArticleId IdType="pubmed">28357805</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina C., Aloisi F., Meinl E. Astrocytes Are Active Players in Cerebral Innate Immunity. Trends Immunol. 2007;28:138&#x2013;145. doi: 10.1016/j.it.2007.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2007.01.005</ArticleId><ArticleId IdType="pubmed">17276138</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden C. Astrocytes Secrete Substance That Kills Motor Neurons in ALS. Science. 2007;316:353. doi: 10.1126/science.316.5823.353a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.316.5823.353a</ArticleId><ArticleId IdType="pubmed">17446359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Borges K. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front. Neurosci. 2017;10:611. doi: 10.3389/fnins.2016.00611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., De Bock K., Van Den Bosch L. Energy Metabolism in ALS: An Underappreciated Opportunity? Acta Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K., Van Den Bosch L. Why Should We Care about Astrocytes in a Motor Neuron Disease? Front. Mol. Med. 2023;3:1047540. doi: 10.3389/fmmed.2023.1047540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmmed.2023.1047540</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistretti P.J., Allaman I. A Cellular Perspective on Brain Energy Metabolism and Functional Imaging. Neuron. 2015;86:883&#x2013;901. doi: 10.1016/j.neuron.2015.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.035</ArticleId><ArticleId IdType="pubmed">25996133</ArticleId></ArticleIdList></Reference><Reference><Citation>Supplie L.M., D&#xfc;king T., Campbell G., Diaz F., Moraes C.T., G&#xf6;tz M., Hamprecht B., Boretius S., Mahad D., Nave K.-A. Respiration-Deficient Astrocytes Survive as Glycolytic Cells In Vivo. J. Neurosci. 2017;37:4231&#x2013;4242. doi: 10.1523/JNEUROSCI.0756-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0756-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596567</ArticleId><ArticleId IdType="pubmed">28314814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Niswender C.M. Progress toward Advanced Understanding of Metabotropic Glutamate Receptors: Structure, Signaling and Therapeutic Indications. Cell Signal. 2014;26:2284&#x2013;2297. doi: 10.1016/j.cellsig.2014.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2014.04.022</ArticleId><ArticleId IdType="pmc">PMC4130774</ArticleId><ArticleId IdType="pubmed">24793301</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H.-N., Sanelli T., Horne P., Pioro E.P., Strong M.J., Rogaeva E., Bilbao J., Zinman L., Robertson J. Lack of Evidence of Monomer/Misfolded Superoxide Dismutase-1 in Sporadic Amyotrophic Lateral Sclerosis. Ann. Neurol. 2009;66:75&#x2013;80. doi: 10.1002/ana.21704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21704</ArticleId><ArticleId IdType="pubmed">19670443</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt K., V&#xe1;radi A., Durant C.F., Moln&#xe1;r E. Oligodendroglial Metabotropic Glutamate Receptors Are Developmentally Regulated and Involved in the Prevention of Apoptosis. J. Neurochem. 2006;99:641&#x2013;656. doi: 10.1111/j.1471-4159.2006.04103.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.04103.x</ArticleId><ArticleId IdType="pubmed">16836654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti F., Bockaert J., Collingridge G.L., Conn P.J., Ferraguti F., Schoepp D.D., Wroblewski J.T., Pin J.P. Metabotropic Glutamate Receptors: From the Workbench to the Bedside. Neuropharmacology. 2011;60:1017&#x2013;1041. doi: 10.1016/j.neuropharm.2010.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2010.10.022</ArticleId><ArticleId IdType="pmc">PMC3787883</ArticleId><ArticleId IdType="pubmed">21036182</ArticleId></ArticleIdList></Reference><Reference><Citation>Anneser J.M.H., Ince P.G., Shaw P.J., Borasio G.D. Differential Expression of MGluR5 in Human Lumbosacral Motoneurons. Neuroreport. 2004;15:271&#x2013;273. doi: 10.1097/00001756-200402090-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200402090-00012</ArticleId><ArticleId IdType="pubmed">15076751</ArticleId></ArticleIdList></Reference><Reference><Citation>Anneser J.M.H., Chahli C., Ince P.G., Borasio G.D., Shaw P.J. Glial Proliferation and Metabotropic Glutamate Receptor Expression in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2004;63:831&#x2013;840. doi: 10.1093/jnen/63.8.831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/63.8.831</ArticleId><ArticleId IdType="pubmed">15330338</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergouts M., Doyen P.J., Peeters M., Opsomer R., Hermans E. Constitutive Downregulation Protein Kinase C Epsilon in HSOD1(G93A) Astrocytes Influences MGluR5 Signaling and the Regulation of Glutamate Uptake. Glia. 2018;66:749&#x2013;761. doi: 10.1002/glia.23279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23279</ArticleId><ArticleId IdType="pubmed">29266405</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Kirchhoff F. Glutamate-Mediated Neuronal-Glial Transmission. J. Anat. 2007;210:651&#x2013;660. doi: 10.1111/j.1469-7580.2007.00734.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7580.2007.00734.x</ArticleId><ArticleId IdType="pmc">PMC2375757</ArticleId><ArticleId IdType="pubmed">17504269</ArticleId></ArticleIdList></Reference><Reference><Citation>Viwatpinyo K., Chongthammakun S. Activation of Group I Metabotropic Glutamate Receptors Leads to Brain-Derived Neurotrophic Factor Expression in Rat C6 Cells. Neurosci. Lett. 2009;467:127&#x2013;130. doi: 10.1016/j.neulet.2009.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.10.020</ArticleId><ArticleId IdType="pubmed">19822193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanumilli S., Roberts P.J. Mechanisms of Glutamate Receptor Induced Proliferation of Astrocytes. Neuroreport. 2006;17:1877&#x2013;1881. doi: 10.1097/WNR.0b013e3280102ee6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0b013e3280102ee6</ArticleId><ArticleId IdType="pubmed">17179862</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean Y.Y., Lercher L.D., Dreyfus C.F. Glutamate Elicits Release of BDNF from Basal Forebrain Astrocytes in a Process Dependent on Metabotropic Receptors and the PLC Pathway. Neuron Glia Biol. 2008;4:35&#x2013;42. doi: 10.1017/S1740925X09000052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1740925X09000052</ArticleId><ArticleId IdType="pubmed">19267952</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezzi P., Volterra A. Imaging Exocytosis and Recycling of Synaptic-Like Microvesicles in Astrocytes. Cold Spring Harb. Protoc. 2014;2014 doi: 10.1101/pdb.prot081711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot081711</ArticleId><ArticleId IdType="pubmed">24786509</ArticleId></ArticleIdList></Reference><Reference><Citation>Panatier A., Vall&#xe9;e J., Haber M., Murai K.K., Lacaille J.-C., Robitaille R. Astrocytes Are Endogenous Regulators of Basal Transmission at Central Synapses. Cell. 2011;146:785&#x2013;798. doi: 10.1016/j.cell.2011.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.07.022</ArticleId><ArticleId IdType="pubmed">21855979</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A., Silverstein P.S., Singh D.P., Kumar A. Involvement of Metabotropic Glutamate Receptor 5, AKT/PI3K Signaling and NF-&#x39a;B Pathway in Methamphetamine-Mediated Increase in IL-6 and IL-8 Expression in Astrocytes. J. Neuroinflamm. 2012;9:52. doi: 10.1186/1742-2094-9-52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-52</ArticleId><ArticleId IdType="pmc">PMC3338363</ArticleId><ArticleId IdType="pubmed">22420994</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren C., Najimi M., Vanhoutte N., Tilleux S., De Hemptinne I., Maloteaux J.M., Hermans E. Acute Up-Regulation of Glutamate Uptake Mediated by MGluR5a in Reactive Astrocytes. J. Neurochem. 2005;94:405&#x2013;416. doi: 10.1111/j.1471-4159.2005.03216.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03216.x</ArticleId><ArticleId IdType="pubmed">15998291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro F.M., DeVries R.A., Hamilton A., Guimaraes I.M., Cregan S.P., Pires R.G.W., Ferguson S.S.G. Metabotropic Glutamate Receptor 5 Knockout Promotes Motor and Biochemical Alterations in a Mouse Model of Huntington&#x2019;s Disease. Hum. Mol. Genet. 2014;23:2030&#x2013;2042. doi: 10.1093/hmg/ddt598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt598</ArticleId><ArticleId IdType="pubmed">24282028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton A., Vasefi M., Vander Tuin C., McQuaid R.J., Anisman H., Ferguson S.S.G. Chronic Pharmacological MGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Cell Rep. 2016;15:1859&#x2013;1865. doi: 10.1016/j.celrep.2016.04.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.077</ArticleId><ArticleId IdType="pubmed">27210751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ure J., Baudry M., Perassolo M. Metabotropic Glutamate Receptors and Epilepsy. J. Neurol. Sci. 2006;247:1&#x2013;9. doi: 10.1016/j.jns.2006.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.03.018</ArticleId><ArticleId IdType="pubmed">16697014</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;len G., Bear M.F. Role for Metabotropic Glutamate Receptor 5 (MGluR5) in the Pathogenesis of Fragile X Syndrome. J. Physiol. 2008;586:1503&#x2013;1508. doi: 10.1113/jphysiol.2008.150722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2008.150722</ArticleId><ArticleId IdType="pmc">PMC2375688</ArticleId><ArticleId IdType="pubmed">18202092</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquet M., Ribeiro F.M., Guadagno J., Esseltine J.L., Ferguson S.S.G., Cregan S.P. Role of Metabotropic Glutamate Receptor 5 Signaling and Homer in Oxygen Glucose Deprivation-Mediated Astrocyte Apoptosis. Mol. Brain. 2013;6:9. doi: 10.1186/1756-6606-6-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-9</ArticleId><ArticleId IdType="pmc">PMC3598502</ArticleId><ArticleId IdType="pubmed">23406666</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Zorec R. Astroglial Signalling in Health and Disease. Neurosci. Lett. 2019;689:1&#x2013;4. doi: 10.1016/j.neulet.2018.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.07.026</ArticleId><ArticleId IdType="pubmed">30031035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Clarke B.E., Taha D.M., Crerar H., Luscombe N.M., Patani R. Meta-Analysis of Human and Mouse ALS Astrocytes Reveals Multi-Omic Signatures of Inflammatory Reactive States. Genome Res. 2022;32:71&#x2013;84. doi: 10.1101/gr.275939.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.275939.121</ArticleId><ArticleId IdType="pmc">PMC8744676</ArticleId><ArticleId IdType="pubmed">34963663</ArticleId></ArticleIdList></Reference><Reference><Citation>Patani R., Hardingham G.E., Liddelow S.A. Functional Roles of Reactive Astrocytes in Neuroinflammation and Neurodegeneration. Nat. Rev. Neurol. 2023;19:395&#x2013;409. doi: 10.1038/s41582-023-00822-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-023-00822-1</ArticleId><ArticleId IdType="pubmed">37308616</ArticleId></ArticleIdList></Reference><Reference><Citation>Migheli A., Cordera S., Bendotti C., Atzori C., Piva R., Schiffer D. S-100b Protein Is Upregulated in Astrocytes and Motor Neurons in the Spinal Cord of Patients with Amyotrophic Lateral Sclerosis. Neurosci. Lett. 1999;261:25&#x2013;28. doi: 10.1016/S0304-3940(98)01001-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(98)01001-5</ArticleId><ArticleId IdType="pubmed">10081918</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Mart&#xed;nez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically Aberrant Astrocytes That Promote Motoneuron Damage in a Model of Inherited Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov V.A., Lyashchenko A.K., Blanco-Redondo B., Jafar-Nejad P., Shneider N.A. Antisense Oligonucleotide Silencing of FUS Expression as a Therapeutic Approach in Amyotrophic Lateral Sclerosis. Nat. Med. 2022;28:104&#x2013;116. doi: 10.1038/s41591-021-01615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey D.R. Nusinersen, an Antisense Oligonucleotide Drug for Spinal Muscular Atrophy. Nat. Neurosci. 2017;20:497&#x2013;499. doi: 10.1038/nn.4508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4508</ArticleId><ArticleId IdType="pubmed">28192393</ArticleId></ArticleIdList></Reference><Reference><Citation>Aartsma-Rus A., Krieg A.M. FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga. Nucleic Acid. Ther. 2017;27:1&#x2013;3. doi: 10.1089/nat.2016.0657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/nat.2016.0657</ArticleId><ArticleId IdType="pmc">PMC5312460</ArticleId><ArticleId IdType="pubmed">27929755</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilmann R., Rouzade-Dominguez M., Saft C., S&#xfc;ssmuth S.D., Priller J., Rosser A., Rickards H., Sch&#xf6;ls L., Pezous N., Gasparini F., et al. A Randomized, Placebo-controlled Trial of AFQ056 for the Treatment of Chorea in Huntington&#x2019;s Disease. Mov. Disord. 2015;30:427&#x2013;431. doi: 10.1002/mds.26174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26174</ArticleId><ArticleId IdType="pubmed">25689146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison F., Keywood C., Wakefield M., Durif F., Corvol J.-C., Eggert K., Lew M., Isaacson S., Bezard E., Poli S.-M., et al. A Phase 2A Trial of the Novel MGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson&#x2019;s Disease. Mov. Disord. 2016;31:1373&#x2013;1380. doi: 10.1002/mds.26659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26659</ArticleId><ArticleId IdType="pubmed">27214664</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiroz J.A., Tamburri P., Deptula D., Banken L., Beyer U., Rabbia M., Parkar N., Fontoura P., Santarelli L. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression. JAMA Psychiatry. 2016;73:675&#x2013;684. doi: 10.1001/jamapsychiatry.2016.0838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2016.0838</ArticleId><ArticleId IdType="pubmed">27304433</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef E.A., Berry-Kravis E., Czech C., Hagerman R.J., Hessl D., Wong C.Y., Rabbia M., Deptula D., John A., Kinch R., et al. Effect of the MGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology. 2018;43:503&#x2013;512. doi: 10.1038/npp.2017.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2017.177</ArticleId><ArticleId IdType="pmc">PMC5770759</ArticleId><ArticleId IdType="pubmed">28816242</ArticleId></ArticleIdList></Reference><Reference><Citation>Trenkwalder C., Stocchi F., Poewe W., Dronamraju N., Kenney C., Shah A., von Raison F., Graf A. Mavoglurant in Parkinson&#x2019;s Patients with l-Dopa-Induced Dyskinesias: Two Randomized Phase 2 Studies. Mov. Disord. 2016;31:1054&#x2013;1058. doi: 10.1002/mds.26585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26585</ArticleId><ArticleId IdType="pubmed">27214258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeschke G., Kolczewski S., Spooren W., Vieira E., Bitter-Stoll N., Boissin P., Borroni E., B&#xfc;ttelmann B., Ceccarelli S., Clemann N., et al. Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators: Discovery of 2-Chloro-4-[1-(4-Fluorophenyl)-2,5-Dimethyl-1 H-Imidazol-4-Ylethynyl]Pyridine (Basimglurant, RO4917523), a Promising Novel Medicine for Psychiatric Diseases. J. Med. Chem. 2015;58:1358&#x2013;1371. doi: 10.1021/jm501642c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm501642c</ArticleId><ArticleId IdType="pubmed">25565255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindemann L., Porter R.H., Scharf S.H., Kuennecke B., Bruns A., von Kienlin M., Harrison A.C., Paehler A., Funk C., Gloge A., et al. Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression. J. Pharmacol. Exp. Ther. 2015;353:213&#x2013;233. doi: 10.1124/jpet.114.222463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.114.222463</ArticleId><ArticleId IdType="pubmed">25665805</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifanese R., Averna M., De Tullio R., Pedrazzi M., Beccaria F., Salamino F., Milanese M., Bonanno G., Pontremoli S., Melloni E. Adaptive Modifications in the Calpain/Calpastatin System in Brain Cells after Persistent Alteration in Ca2+ Homeostasis. J. Biol. Chem. 2010;285:631&#x2013;643. doi: 10.1074/jbc.M109.031674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031674</ArticleId><ArticleId IdType="pmc">PMC2804211</ArticleId><ArticleId IdType="pubmed">19880516</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifanese R., Averna M., De Tullio R., Pedrazzi M., Milanese M., Bonifacino T., Bonanno G., Salamino F., Pontremoli S., Melloni E. Role of Calpain-1 in the Early Phase of Experimental ALS. Arch. Biochem. Biophys. 2014;562:1&#x2013;8. doi: 10.1016/j.abb.2014.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2014.08.006</ArticleId><ArticleId IdType="pubmed">25151305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivest S. Regulation of Innate Immune Responses in the Brain. Nat. Rev. Immunol. 2009;9:429&#x2013;439. doi: 10.1038/nri2565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2565</ArticleId><ArticleId IdType="pubmed">19461673</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Glial Cells in Amyotrophic Lateral Sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Carr&#xec; M.T. Lessons from Models of SOD1-Linked Familial ALS. Trends Mol. Med. 2004;10:393&#x2013;400. doi: 10.1016/j.molmed.2004.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2004.06.009</ArticleId><ArticleId IdType="pubmed">15310460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Gong B., Gao Y., Yuan L. An in Vitro Study on the Stimulatory Effects of Extracellular Glutamate on Astrocytes. Mol. Biol. Rep. 2023 doi: 10.1007/s11033-023-08601-3. ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-023-08601-3</ArticleId><ArticleId IdType="pubmed">37344642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud S., Gharagozloo M., Simard C., Gris D. Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release. Cells. 2019;8:184. doi: 10.3390/cells8020184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020184</ArticleId><ArticleId IdType="pmc">PMC6406900</ArticleId><ArticleId IdType="pubmed">30791579</ArticleId></ArticleIdList></Reference><Reference><Citation>Satarker S., Bojja S.L., Gurram P.C., Mudgal J., Arora D., Nampoothiri M. Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders. Cells. 2022;11:1139. doi: 10.3390/cells11071139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071139</ArticleId><ArticleId IdType="pmc">PMC8997779</ArticleId><ArticleId IdType="pubmed">35406702</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;langer M., Allaman I., Magistretti P.J. Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation. Cell Metab. 2011;14:724&#x2013;738. doi: 10.1016/j.cmet.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.08.016</ArticleId><ArticleId IdType="pubmed">22152301</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubert A., Costalat R., Magistretti P.J., Pellerin L. Brain Lactate Kinetics: Modeling Evidence for Neuronal Lactate Uptake upon Activation. Proc. Natl. Acad. Sci. USA. 2005;102:16448&#x2013;16453. doi: 10.1073/pnas.0505427102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0505427102</ArticleId><ArticleId IdType="pmc">PMC1297516</ArticleId><ArticleId IdType="pubmed">16260743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadenas E., Davies K.J.A. Mitochondrial Free Radical Generation, Oxidative Stress, and Aging11This Article Is Dedicated to the Memory of Our Dear Friend, Colleague, and Mentor Lars Ernster (1920&#x2013;1998), in Gratitude for All He Gave to Us. Free Radic. Biol. Med. 2000;29:222&#x2013;230. doi: 10.1016/S0891-5849(00)00317-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00317-8</ArticleId><ArticleId IdType="pubmed">11035250</ArticleId></ArticleIdList></Reference><Reference><Citation>Percie du Sert N., Hurst V., Ahluwalia A., Alam S., Avey M.T., Baker M., Browne W.J., Clark A., Cuthill I.C., Dirnagl U., et al. The ARRIVE Guidelines 2.0: Updated Guidelines for Reporting Animal Research. Br. J. Pharmacol. 2020;177:3617&#x2013;3624. doi: 10.1111/bph.15193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15193</ArticleId><ArticleId IdType="pmc">PMC7393194</ArticleId><ArticleId IdType="pubmed">32662519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>